Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
D 8.19 -3.66% -0.31
DXR closed down 3.66 percent on Monday, March 18, 2024, on 89 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -3.66%
Weak + Overbought Other -3.66%
Overbought Stochastic Strength -3.66%
Narrow Range Bar Range Contraction -2.90%
Weak + Overbought Other -2.90%

   Recent Intraday Alerts

Alert Time
Down 3% about 14 hours ago
Fell Below Previous Day's Low about 18 hours ago
Down 2 % about 18 hours ago
Down 1% about 18 hours ago
Rose Above Previous Day's High 4 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Daxor Corporation Description

Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Disorders Hypertension Heart Failure Hematology Anemia Radiology Blood Transfusion Medicine Red Blood Cell Science Kidney Failure Blood Transfusion Medical Device Manufacturing Blood Volume Hematopathology Polycythemia Syncope

Is DXR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.3
52 Week Low 7.11
Average Volume 2,533
200-Day Moving Average 9.01
50-Day Moving Average 8.67
20-Day Moving Average 8.04
10-Day Moving Average 8.13
Average True Range 0.38
RSI (14) 48.98
ADX 29.15
+DI 21.43
-DI 30.95
Chandelier Exit (Long, 3 ATRs) 7.76
Chandelier Exit (Short, 3 ATRs) 8.32
Upper Bollinger Bands 8.89
Lower Bollinger Band 7.18
Percent B (%b) 0.59
BandWidth 21.30
MACD Line -0.04
MACD Signal Line -0.15
MACD Histogram 0.1023
Fundamentals Value
Market Cap 31.84 Million
Num Shares 3.89 Million
EPS 0.05
Price-to-Earnings (P/E) Ratio 154.51
Price-to-Sales 98.79
Price-to-Book 4.99
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.28
Resistance 3 (R3) 8.29 8.27 8.27
Resistance 2 (R2) 8.27 8.25 8.27 8.26
Resistance 1 (R1) 8.23 8.23 8.22 8.22 8.26
Pivot Point 8.21 8.21 8.20 8.20 8.21
Support 1 (S1) 8.17 8.19 8.16 8.16 8.12
Support 2 (S2) 8.15 8.17 8.14 8.12
Support 3 (S3) 8.11 8.15 8.11
Support 4 (S4) 8.10